Who Each Option Works Best For Telehealth GLP-1 programs are the stronger choice for convenience, speed, and routine monitoring
The combined efforts of Wellstar's care teams and patients as part of the ERAS program proved a significant 24% reduction in 30-day readmissions, a 61% reduction in pain medications used, and a patient satisfaction rate of 99%
This approval makes Eli Lillys oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug for weight loss available in pill form, after Wegovy, which gained approval in December 2025
Results: scRNA-seq analysis revealed that a subset of MDMs expressed tissue restoration-related genes ( Arg1 , Il10 , and matrix metalloproteases), referred to as restorative MDMs, which highly expressed Slc7a11 encoding the cystine/glutamate antiporter (xCT) in both mouse and human